Richard A. Edlin, Director at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 6,800 shares at $30.99 ($211K) on 2022-09-06, disclosed to the SEC on 2022-09-08.
Open-market sale of $211k EGRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.